Global Astaxanthin 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Astaxanthin market size was valued at US$ 205 million in 2024 and is forecast to a readjusted size of USD 376 million by 2031 with a CAGR of 9.1% during review period.
Global core astaxanthin manufacturers include Royal DSM N.V., Cyanotech Corporation, Fuji Chemical Industries Co., Ltd., BASF and BGG. The top five manufacturers account for approximately 68% of the global market share.
From a production perspective, Europe is the largest anthocyanin production region in the world, accounting for nearly 56% of the market share. The second and third places are China and North America, accounting for 23% and 15% respectively.
In terms of product type, natural astaxanthin is the largest market segment, accounting for more than 70% of the market. At the same time, in terms of application, feed is the largest application field, accounting for 55% of the market.
This report is a detailed and comprehensive analysis for global Astaxanthin market. Both...Read more | USD 3,480.00 |
Global Oxyclozanide 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Oxyclozanide market size was valued at US$ 34.8 million in 2024 and is forecast to a readjusted size of USD 65.8 million by 2031 with a CAGR of 9.7% during review period.
Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fascioliasis in ruminants mainly domestic animals such as cattle, sheep, and goats. It mainly acts by uncoupling of oxidative phosphorylation in flukes.
Global Oxyclozanide main players are Siflon Drug, Yabang, Gharda, ASCENT PHARMA, Aarambh Life Science, etc. Top five companies hold a share above 50%. Africa is the largest market, with a share about 30%.
This report is a detailed and comprehensive analysis for global Oxyclozanide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that...Read more | USD 3,480.00 |
Global Bio Pharma Buffer 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Bio Pharma Buffer market size was valued at US$ 994 million in 2024 and is forecast to a readjusted size of USD 1591 million by 2031 with a CAGR of 7.0% during review period.
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to...Read more | USD 3,480.00 |
Global Transdermal Patch 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Transdermal Patch market size was valued at US$ 7498 million in 2024 and is forecast to a readjusted size of USD 9524 million by 2031 with a CAGR of 3.5% during review period.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery...Read more | USD 3,480.00 |
Global Rabies Vaccine 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Rabies Vaccine market size was valued at US$ 1036 million in 2024 and is forecast to a readjusted size of USD 1350 million by 2031 with a CAGR of 3.9% during review period.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
This report is a detailed and comprehensive analysis for global Rabies Vaccine market. Both...Read more | USD 3,480.00 |
0 items USD 0.00
Printer version
Send by email
